We are live on ! Find out more
IMNN icon

Imunon
IMNN

21 hedge funds and large institutions have $573K invested in Imunon in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.09% less ownership

Funds ownership: 0.53% → 0.44% (-0.09%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

30% less capital invested

Capital invested by funds: $818K → $573K (-$245K)

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$21.6K
2
TRCT
Tower Research Capital (TRC)
New York
+$2.29K
3
UBS Group
UBS Group
Switzerland
+$943
4
Citigroup
Citigroup
New York
+$442
5
Vanguard Group
Vanguard Group
Pennsylvania
+$173

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$54K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$44.7K
3
VF
Virtu Financial
New York
-$18K
4
IAMOG
Investors Asset Management of Georgia
Georgia
-$8K
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.21K

IMNN Hedge Fund Activity: Q4 2022 in Review

21 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2022, worth a combined $573K — down 30% from $818K a quarter earlier.

Fund positioning in IMNN was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 5 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $21.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $54K sold.

  • 21 institutional investors held Imunon (IMNN) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $573K of Imunon stock for Q4 2022, down 30% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q4 2022 and 4 closed out, a net change of 0 holders.
  • The largest Imunon buyer in Q4 2022 was Jane Street, an estimated $21.6K added.
  • The largest Imunon seller in Q4 2022 was Citadel Advisors, an estimated $54K sold.

Based on aggregated 13F filings for Q4 2022.